Kazuo Tsubaki

All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group [see comments]

A Kanamaru, Y Takemoto, Mitsune Tanimoto et al. · Blood · 1995 · 250 citations

Medicine, Hematology, Oncology +7

Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group.

Norio Asou, Koichi Adachi, Jun‐ichi Tamura et al. · Journal of Clinical Oncology · 1998 · 208 citations

Medicine, Oncology, Pharmacotherapy +14

A randomized trial comparing interferon-alpha with busulfan for newly diagnosed chronic myelogenous leukemia in chronic phase

Kazunori Ohnishi, R Ohno, Masao Tomonaga et al. · Blood · 1995 · 188 citations · Full text

Medicine, Hematology, Oncology +8

Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment

Masaya Okada, Jun Imagawa, Hideo Tanaka et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 117 citations · Full text

Medicine, Oncology, Pharmacology +9

Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group.

T Kobayashi, Shuichi Miyawaki, Mitsune Tanimoto et al. · Journal of Clinical Oncology · 1996 · 103 citations

Medicine, Oncology, Pharmacology +14